Affinity Asset Advisors’s Avalo Therapeutics AVTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Sell |
607,872
-49,282
| -7% | -$246K | 0.41% | 45 |
|
|
2025
Q1 | $5.26M | Buy |
657,154
+106,389
| +19% | +$852K | 0.5% | 31 |
|
|
2024
Q4 | $4.09M | Buy |
550,765
+505,765
| +1,124% | +$3.76M | 0.55% | 37 |
|
|
2024
Q3 | $426K | Hold |
45,000
| – | – | 0.06% | 71 |
|
|
2024
Q2 | $561K | Buy |
45,000
+35,000
| +350% | +$436K | 0.06% | 75 |
|
|
2024
Q1 | $218K | Buy |
+10,000
| New | +$218K | 0.03% | 75 |
|